feed,title,long_url,short_url
SeekingAlpha,Catalyst Pharma gains U.S. rights to Eisai epilepsy drug Fycompa,https://seekingalpha.com/news/3918752,
SeekingAlpha,Entrada stock tumbles ~35% as FDA puts application for muscle wasting therapy on hold,https://seekingalpha.com/news/3918751,
